Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Both platforms serve similar patient profiles
Clinical efficacy The clinical efficacy and safety of these combination products has been established through a series of phase 3 trials (DUAL clinical program for IDegLira and LixiLan for IGlarLixi)
Spinal Cord Injury Spinal cord injury (SCI) leads to significant disruption of the BSCB, exacerbating inflammation, oxidative stress, edema, bleeding, and neuronal damage [202,203,204]
Dolinsky VW, Morton JS, Oka T, Robillard-Frayne I, Bagdan M, Lopaschuk GD, et al
US$ 26.50
US$ 20.12
US$ 25.63
US$ 23.66
